Flagship explainer
How Regenerative Medical Technology Group Inc. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $5.1M | 100% |
| |
| Cost of revenue | $2.3M | 45% |
|
| $2.8M | 55% |
| |
| −$867162 | −17% |
| |
| Income before tax | −$9.5M | −185% |
|
| Income tax | −$1.6M | −32% |
|
| −$7.8M | −153% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001213900-26-056841